Axela Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Axela Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0141
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. The company creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products through a network of distributors in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Axela is headquartered in Toronto, Ontario, Canada.

Axela Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Axela Inc, Medical Equipment, Deal Details 10
Partnerships 10
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
Asset Transactions 16
ANGLE Acquires Assets from Axela 16
Acquisition 17
Axela Mulls Offering Itself For Sale 17
Axela Inc – Key Competitors 18
Axela Inc – Key Employees 19
Axela Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
Apr 10, 2017: Rapid blood test for intracranial hemorrhage in well appearing infants: a comprehensive brain injury study using Axela’s Flow-Thru Chip platform 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Axela Inc, Medical Equipment, Key Facts 2
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Deals By Market, 2012 to YTD 2018 8
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
ANGLE Acquires Assets from Axela 16
Axela Mulls Offering Itself For Sale 17
Axela Inc, Key Competitors 18
Axela Inc, Key Employees 19

List of Figures
Axela Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Axela Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Robert Walters Plc (RWA):企業の財務・戦略的SWOT分析
    Summary Robert Walters Plc (Robert Walters) is a recruitment and consultancy service provider. The company offers placements of professionals on permanent, contract and interim positions. It offers recruitment services for accountancy and finance, banking and financial services, executive search, pr …
  • Dalian Port (PDA) Co Ltd (2880):石油・ガス:M&Aディール及び事業提携情報
    Summary Dalian Port (PDA) Co Ltd (Dalian), a subsidiary of Dalian Port Corp Ltd is an oil and gas company that offers port and logistic services. The company offers services such as passenger and roll-on, roll-off terminal, bulk grain terminal, and related logistics services. It also provides oil an …
  • Japan Post Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Strayer Education Inc (STRA):企業の財務・戦略的SWOT分析
    Summary Strayer Education Inc (Strayer) operates as an educational service provider that offers undergraduate and graduate degree programs. The institute’s degree programs include business administration, accounting, information technology, education, health services administration and public admini …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Meredith Corporation (MDP):企業の財務・戦略的SWOT分析
    Meredith Corporation (MDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hargreaves Lansdown PLC:企業の戦略・SWOT・財務情報
    Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank of Shanghai Co., Ltd.:企業の戦略・SWOT・財務情報
    Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operation …
  • Saskatchewan Power Corp:企業の戦略的SWOT分析
    Saskatchewan Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • QGEP Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析
    Summary QGEP Participacoes SA (QGEP), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company's exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambuco-P …
  • AngloGold Ashanti Ltd:企業の戦略・SWOT・財務情報
    AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析
    Summary Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, …
  • Apexigen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of cancer. The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell responses. It also …
  • Orient Pharma Co Ltd (4166):製薬・医療:M&Aディール及び事業提携情報
    Summary Orient Pharma Co Ltd (Oripharm) is a pharmaceutical company that manufactures and distributes therapeutic drugs. The company develops drugs for anti-psychotics, Alzheimer’s disease, psychostimulants and Parkinson’s disease. Its drug delivery technologies include multi stages controlled techn …
  • DKSH Holding Ltd. (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd. (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Takashimaya Company, Limited:企業の戦略・SWOT・財務分析
    Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆